AMGN · 10-Q · 2026Q3 · Full report

Repatha Demand Growth

AMGEN INC · 2026-11-04 · Importance 64 · Surprise 56

Global Repatha sales increased for the three and nine months ended September 30, 2026, primarily because of volume growth. Nine-month sales rose to $2.914 billion from $2.146 billion, an increase of approximately 36%. Sales increased in both the U.S. and the rest of the world (ROW).

Key facts

• Global Repatha sales increased in the three and nine months ended September 30, 2026, primarily driven by volume growth. source